Peripheral Leukocytosis Predicts Cognitive Decline but Not Behavioral Disturbances: A Nationwide Study of Alzheimer’s and Parkinson’s Disease Patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Peripheral Leukocytosis Predicts Cognitive Decline but Not Behavioral Disturbances: A Nationwide Study of Alzheimer’s and Parkinson’s Disease Patients ; volume:50 ; number:2 ; year:2021 ; pages:143-152 ; extent:10
Dementia and geriatric cognitive disorders ; 50, Heft 2 (2021), 143-152 (gesamt 10)
- Creator
-
Unda, Santiago R.
Antoniazzi, Aldana M.
Altschul, David J.
Marongiu, Roberta
- DOI
-
10.1159/000516340
- URN
-
urn:nbn:de:101:1-2021090200184766400783
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Unda, Santiago R.
- Antoniazzi, Aldana M.
- Altschul, David J.
- Marongiu, Roberta
Other Objects (12)
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease
Impaired 24-h activity patterns are associated with an increased risk of Alzheimer’s disease, Parkinson’s disease, and cognitive decline
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease
Impaired 24-h activity patterns are associated with an increased risk of Alzheimer’s disease, Parkinson’s disease, and cognitive decline
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease